Pdt Partners, LLC Reata Pharmaceuticals Inc Transaction History

Pdt Partners, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$79.22 - $105.37 $3.04 Million - $4.04 Million	-38,343 Reduced 88.86%	4,806 $490,000
Q1 2023 May 15, 2023	BUY	$30.85 - $93.17 $154 - $465	5 Added 0.01%	43,149 $3.92 Million
Q4 2022 Feb 14, 2023	SELL	$22.15 - $42.11 $332,028 - $631,228	-14,990 Reduced 25.79%	43,144 $1.64 Million
Q3 2022 Nov 14, 2022	SELL	$19.41 - $36.49 $99,573 - $187,193	-5,130 Reduced 8.11%	58,134 $1.46 Million
Q2 2022 Aug 15, 2022	BUY	$20.71 - $36.5 $1.1 Million - $1.93 Million	52,907 Added 510.83%	63,264 $1.92 Million
Q1 2022 May 16, 2022	BUY	$24.12 - $39.6 $249,810 - $410,137	10,357 New	10,357 $339,000

62.7K

Ticker RETA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,583,200
Description
Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...

Get notified when there are updates to the investment portfolio of Pdt Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Pdt Partners, LLC with notifications on news.